CHANGES IN DIGOXIN AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACEI) USE IN INFANTS WITH SINGLE VENTRICLE (SV) PHYSIOLOGY FOLLOWING LANDMARK PUBLICATIONS

The impact of landmark studies on change in clinical practice has been poorly studied. We used the Pediatric Health Information System (PHIS) to assess Digoxin and ACEI use in infants with SV physiology after publication of the National Pediatric Cardiology Quality Improvement Collaborative study